A detailed history of Bowen Hanes & CO Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 36,450 shares of REGN stock, worth $26 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
36,450
Previous 34,790 4.77%
Holding current value
$26 Million
Previous $36.6 Million 4.79%
% of portfolio
1.01%
Previous 1.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $1.7 Million - $1.99 Million
1,660 Added 4.77%
36,450 $38.3 Million
Q2 2024

Aug 12, 2024

BUY
$883.2 - $1071.19 $3.67 Million - $4.45 Million
4,150 Added 13.54%
34,790 $36.6 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $27.7 Million - $30.4 Million
30,640 New
30,640 $29.5 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bowen Hanes & CO Inc Portfolio

Follow Bowen Hanes & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.